Blood Science (Jan 2022)

The novel SLC40A1 (T419I) variant results in a loss-of-function phenotype and may provide insights into the mechanism of large granular lymphocytic leukemia and pure red cell aplasia

  • Hongfei Wu,
  • Xiang Ren,
  • Meili Ge,
  • Peiyuan Dong,
  • Shichong Wang,
  • Huiming Yi,
  • Xingxin Li,
  • Jiali Huo,
  • Xuan Zheng,
  • Mengying Gao,
  • Jinbo Huang,
  • Jing Zhang,
  • Min Wang,
  • Peng Jin,
  • Neng Nie,
  • Yingqi Shao,
  • Yizhou Zheng

DOI
https://doi.org/10.1097/BS9.0000000000000099
Journal volume & issue
Vol. 4, no. 1
pp. 29 – 37

Abstract

Read online

Abstract. Variants in the solute carrier family 40 member 1 (SLC40A1) gene are the molecular basis of ferroportin disease, which is an autosomal dominant hereditary hemochromatosis. Here, we present a patient with pure red cell aplasia (PRCA) and large granular lymphocytic leukemia (LGLL) associated with an extremely high levels of serum ferritin and iron overload syndrome. Whole exon sequencing revealed a novel heterozygous variant in SLC40A1 (p.T419I), which was found in his daughter as well. A series of functional studies in vitro of the T419I variant in ferroportin were conducted and the results revealed a reduced capacity of iron export from cells without changes in protein localization and its sensitivity to hepcidin. Intracellular iron storage in mutated cells was significantly higher than that of wild-type. These findings suggest that the novel variant p.T419I can cause the classical form of ferroportin disease and an elevated intracellular iron level indicates a potential novel pathogenic mechanism underlying PRCA and LGLL.